XML 61 R36.htm IDEA: XBRL DOCUMENT
v3.6.0.2

Supplemental data | 12 Months Ended
--- | ---
Dec. 31, 2016
Organization Consolidation And Presentation Of Financial Statements [Abstract] |
Supplemental data (unaudited) |
29. | Supplemental data (unaudited)
The following information is presented as supplemental data as required by the indentures governing the Company’s Senior Notes. Condensed Consolidating Statements of Income
|  | Consolidated Total |  |  | Physician Groups |  |  | Unrestricted Subsidiaries |  |  | Company and Restricted Subsidiaries(1) |
For the year ended December 31, 2016 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Patient services revenues |  | $ | 10,354,161 |  |  | $ | 449,473 |  |  | $ | — |  |  | $ | 9,904,688 |
Less: Provision for uncollectible accounts |  |  | (451,353 | ) |  |  | (12,696 | ) |  |  | — |  |  |  | (438,657 | )
Net patient service revenues |  |  | 9,902,808 |  |  |  | 436,777 |  |  |  | — |  |  |  | 9,466,031 |
Capitated revenues |  |  | 3,518,679 |  |  |  | 1,617,794 |  |  |  | — |  |  |  | 1,900,885 |
Other revenues |  |  | 1,323,618 |  |  |  | 32,938 |  |  |  | — |  |  |  | 1,290,680 |
Total net revenues |  |  | 14,745,105 |  |  |  | 2,087,509 |  |  |  | — |  |  |  | 12,657,596 |
Operating expenses and charges |  |  | 12,850,562 |  |  |  | 2,035,001 |  |  |  | 110 |  |  |  | 10,815,451 |
Operating income |  |  | 1,894,543 |  |  |  | 52,508 |  |  |  | (110 | ) |  |  | 1,842,145 |
Debt expense |  |  | (414,382 | ) |  |  | (10,140 | ) |  |  | — |  |  |  | (404,242 | )
Other income, net |  |  | 8,734 |  |  |  | 576 |  |  |  | — |  |  |  | 8,158 |
Income tax expense |  |  | 455,813 |  |  |  | 10,643 |  |  |  | (44 | ) |  |  | 445,214 |
Net income |  |  | 1,033,082 |  |  |  | 32,301 |  |  |  | (66 | ) |  |  | 1,000,847 |
Less: Net income attributable to noncontrolling interests |  |  | (153,208 | ) |  |  | — |  |  |  | — |  |  |  | (153,208 | )
Net income attributable to DaVita Inc. |  | $ | 879,874 |  |  | $ | 32,301 |  |  | $ | (66 | ) |  | $ | 847,639 |
Condensed Consolidating Statements of Comprehensive Income
|  | Consolidated Total |  |  | Physician Groups |  |  | Unrestricted Subsidiaries |  |  | Company and Restricted Subsidiaries(1) |
For the year ended December 31, 2016 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (losses) |  | $ | 1,033,082 |  |  | $ | 32,301 |  |  | $ | (66 | ) |  | $ | 1,000,847 |
Other comprehensive losses |  |  | (29,627 | ) |  |  | — |  |  |  | — |  |  |  | (29,627 | )
Total comprehensive income (losses) |  |  | 1,003,455 |  |  |  | 32,301 |  |  |  | (66 | ) |  |  | 971,220 |
Less: Comprehensive income attributable to noncontrolling interest |  |  | (153,398 | ) |  |  | — |  |  |  | — |  |  |  | (153,398 | )
Comprehensive income (losses) attributable to DaVita Inc. |  | $ | 850,057 |  |  | $ | 32,301 |  |  | $ | (66 | ) |  | $ | 817,822 |
(1) | After the elimination of the unrestricted subsidiaries and the physician groups
Condensed Consolidating Balance Sheets
|  | Consolidated Total |  |  | Physician Groups |  |  | Unrestricted Subsidiaries |  |  | Company and Restricted Subsidiaries(1) |
As of December 31, 2016 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 913,187 |  |  | $ | 104,691 |  |  | $ | — |  |  | $ | 808,496 |
Accounts receivable, net |  |  | 1,917,302 |  |  |  | 207,430 |  |  |  | — |  |  |  | 1,709,872 |
Other current assets |  |  | 1,149,739 |  |  |  | 15,124 |  |  |  | — |  |  |  | 1,134,615 |
Total current assets |  |  | 3,980,228 |  |  |  | 327,245 |  |  |  | — |  |  |  | 3,652,983 |
Property and equipment, net |  |  | 3,175,367 |  |  |  | 1,378 |  |  |  | — |  |  |  | 3,173,989 |
Amortizable intangibles, net |  |  | 1,527,767 |  |  |  | 4,858 |  |  |  | — |  |  |  | 1,522,909 |
Other long-term assets |  |  | 650,578 |  |  |  | 78,215 |  |  |  | 2,714 |  |  |  | 569,649 |
Goodwill |  |  | 9,407,317 |  |  |  | 16,405 |  |  |  | — |  |  |  | 9,390,912 |
Total assets |  | $ | 18,741,257 |  |  | $ | 428,101 |  |  | $ | 2,714 |  |  | $ | 18,310,442 |
Current liabilities |  | $ | 2,696,445 |  |  | $ | 223,302 |  |  | $ | — |  |  | $ | 2,473,143 |
Payables to parent |  |  | — |  |  |  | 56,699 |  |  |  | 2,714 |  |  |  | (59,413 | )
Long-term debt and other long-term liabilities |  |  | 10,221,813 |  |  |  | 44,094 |  |  |  | — |  |  |  | 10,177,719 |
Noncontrolling interests subject to put provisions |  |  | 973,258 |  |  |  | — |  |  |  | — |  |  |  | 973,258 |
Total DaVita Inc. shareholders' equity |  |  | 4,648,047 |  |  |  | 104,006 |  |  |  | — |  |  |  | 4,544,041 |
Noncontrolling interests not subject to put provisions |  |  | 201,694 |  |  |  | — |  |  |  | — |  |  |  | 201,694 |
Shareholders' equity |  |  | 4,849,741 |  |  |  | 104,006 |  |  |  | — |  |  |  | 4,745,735 |
Total liabilities and shareholder's equity |  | $ | 18,741,257 |  |  | $ | 428,101 |  |  | $ | 2,714 |  |  | $ | 18,310,442 |
Condensed Consolidating Statements of Cash Flows
|  | Consolidated Total |  |  | Physician Groups |  |  | Unrestricted Subsidiaries |  |  | Company and Restricted Subsidiaries(1) |
For the year ended December 31, 2016 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash flows from operating activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income |  | $ | 1,033,082 |  |  | $ | 32,301 |  |  | $ | (66 | ) |  | $ | 1,000,847 |
Changes in operating and intercompany assets and liabilities and non-cash items included in net income |  |  | 930,362 |  |  |  | 131,863 |  |  |  | 66 |  |  |  | 798,433 |
Net cash provided by operating activities |  |  | 1,963,444 |  |  |  | 164,164 |  |  |  | — |  |  |  | 1,799,280 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Additions of property and equipment |  |  | (829,095 | ) |  |  | (863 | ) |  |  | — |  |  |  | (828,232 | )
Acquisitions and divestitures, net |  |  | (563,856 | ) |  |  | — |  |  |  | — |  |  |  | (563,856 | )
Proceeds from asset sales |  |  | 64,725 |  |  |  | — |  |  |  | — |  |  |  | 64,725 |
Investments and other items |  |  | 126,558 |  |  |  | (3,014 | ) |  |  | — |  |  |  | 129,572 |
Net cash used in investing activities |  |  | (1,201,668 | ) |  |  | (3,877 | ) |  |  | — |  |  |  | (1,197,791 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Long-term debt and related financing costs, net |  |  | (124,442 | ) |  |  | (4 | ) |  |  | — |  |  |  | (124,438 | )
Intercompany |  |  | — |  |  |  | (143,837 | ) |  |  | — |  |  |  | 143,837 |
Other items |  |  | (1,227,539 | ) |  |  | — |  |  |  | — |  |  |  | (1,227,539 | )
Net cash used in financing activities |  |  | (1,351,981 | ) |  |  | (143,841 | ) |  |  | — |  |  |  | (1,208,140 | )
Effect of exchange rate changes on cash |  |  | 4,276 |  |  |  | — |  |  |  | — |  |  |  | 4,276 |
Net increase (decrease) in cash |  |  | (585,929 | ) |  |  | 16,446 |  |  |  | — |  |  |  | (602,375 | )
Cash at beginning of the year |  |  | 1,499,116 |  |  |  | 88,245 |  |  |  | — |  |  |  | 1,410,871 |
Cash at the end of the year |  | $ | 913,187 |  |  | $ | 104,691 |  |  | $ | — |  |  | $ | 808,496 |
(1) | After the elimination of the unrestricted subsidiaries and the physician groups

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration